Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Farnesol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.83 |
| ▸ | MAPT | P10636 | 3/20 | 0.83 |
| ▸ | MEN1 | O00255 | 3/20 | 0.83 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.83 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.83 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.83 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.83 |
| ▸ | FNTA | P49354 | 5/20 | 0.61 |
| ▸ | FNTB | P49356 | 5/20 | 0.61 |
| ▸ | SQLE | Q14534 | 5/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.59 |
| ▸ | ATM | Q13315 | 1/20 | 0.59 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Farnesol SCHEMBL29087994 | 1.00 | KMT2A (0.83) | KMT2AMAPTMEN1CYP3A4ALOX15 | |
| Geranylgeraniol SCHEMBL1573864 | 1.00 | KMT2A (0.83) | KMT2AMAPTMEN1CYP3A4ALOX15 | |
| Geraniol SCHEMBL9769106 | 0.98 | KMT2A (0.83) | KMT2AMAPTMEN1CYP3A4ALOX15 | |
| Geraniol SCHEMBL20481434 | 0.98 | KMT2A (0.83) | KMT2AMAPTMEN1CYP3A4ALOX15 | |
| Geraniol SCHEMBL3664268 | 0.98 | KMT2A (0.83) | KMT2AMAPTMEN1CYP3A4ALOX15 | |
| Geraniol SCHEMBL57142 | 0.98 | KMT2A (0.83) | KMT2AMAPTMEN1CYP3A4ALOX15 | |
| Nerol SCHEMBL28146868 | 0.98 | KMT2A (0.83) | KMT2AMAPTMEN1CYP3A4ALOX15 | |
| Farnesol SCHEMBL32674556 | 0.94 | KMT2A (0.74) | KMT2AMAPTMEN1CYP3A4ALOX15 | |
| Nerol SCHEMBL30742830 | 0.94 | KMT2A (0.74) | KMT2AMAPTMEN1CYP3A4ALOX15 | |
| Nerol SCHEMBL28538301 | 0.94 | KMT2A (0.83) | KMT2AMAPTMEN1CYP3A4ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 167 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119876059-A | Biological catalytic synthesis method of ambrox | 天津大学浙江研究院(绍兴) | 2025-04-25 | — | — | CN | claimed |
| CN-119185405-B | Gaultheria tenuifolia volatile oil and application thereof | 山东大学 | 2025-02-28 | — | — | CN | claimed |
| US-12194020-B2 | Reversing baldness through cannabinoid receptor activation | POSTREL RICHARD (US) | 2025-01-14 | — | — | US | claimed |
| CN-119185405-A | Gaultheria tenuifolia volatile oil and application thereof | 山东大学 | 2024-12-27 | — | — | CN | claimed |
| CN-118203512-A | Natural mild oil-control anti-dandruff solid shampoo and preparation method thereof | 广州美思生物技术有限公司 | 2024-06-18 | — | — | CN | claimed |
| CN-116392401-A | Natural mild oil-control anti-dandruff solid shampoo and preparation method thereof | 广州美思生物技术有限公司 | 2023-07-07 | — | — | CN | claimed |
| CN-116035003-A | Biodegradable thrips attracting and smearing adhesive and application method thereof | 福建省农业科学院植物保护研究所 | 2023-05-02 | — | — | CN | claimed |
| CN-114917162-A | Natural plant shampoo with mild surface activity, mild color and luster and preparation method thereof | 广州美思生物技术有限公司 | 2022-08-19 | — | — | CN | claimed |
| US-20220249434-A1 | Reversal of Baldness in Men and Women through Cannabinoid Receptor Activation | POSTREL RICHARD (US) | 2022-08-11 | — | — | US | claimed |
| US-11331300-B2 | Reversing baldness through follicle regeneration | POSTREL RICHARD (US) | 2022-05-17 | — | — | US | claimed |
| CN-111272906-A | Method for determining flower fragrance components in main stream smoke of cigarette | 中国烟草总公司郑州烟草研究院 | 2020-06-12 | — | — | CN | claimed |
| US-20260034186-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | RIZUN NODARI (US) | 2026-02-05 | — | — | US | disclosed |
| US-12427176-B2 | Enriched mineral pitch resin products and methods of manufacturing enriched mineral pitch resin products | RIZUN NODARI (US) | 2025-09-30 | — | — | US | disclosed |
| CN-119876059-A | Biological catalytic synthesis method of ambrox | 天津大学浙江研究院(绍兴) | 2025-04-25 | — | — | CN | disclosed |
| CN-119876059-A | Biological catalytic synthesis method of ambrox | 天津大学浙江研究院(绍兴) | 2025-04-25 | — | — | CN | disclosed |
| US-5484597-A | Clear hydroalcholic cosmetic microemulsions | CHESEBROUGH-POND'S USA CO. (US) | 1996-01-16 | — | — | US | disclosed |
| US-5482710-A | COSMETICS FOR HEALING WITH KERATOLYTIC AGENTS AND ANTIIRRITANT | CHESEBROUGH-POND'USA CO., DIVISION OF CONOPCO, INC. (US) | 1996-01-09 | — | — | US | disclosed |
| WO-1995003779-A1 | COSMETIC COMPOSITION CONTAINING HYDROXYACIDS | UNILEVER PLC (GB) | 1995-02-09 | — | — | WO | disclosed |
| WO-1995003778-A1 | COSMETIC COMPOSITION | UNILEVER PLC (GB) | 1995-02-09 | — | — | WO | disclosed |
| WO-1995003772-A1 | HYDROALCOHOLIC COSMETIC MICROEMULSIONS | UNILEVER PLC (GB) | 1995-02-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260034186-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | TRPV1, SOST, RUNX1 | KMT2A 2506/4885MAPT 37/4885MEN1 1242/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.